v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss         $ (84,363) $ (79,042)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Reduction in the carrying amount of ROU assets, operating         1,206 1,106  
Reduction in the carrying amount of ROU assets, finance $ 80   $ 80   240 240  
Stock-based compensation expense         12,137 9,419  
Depreciation and amortization expense         233 195  
Non-cash acquired in-process research and development stock-based acquisition expense         2,165 0  
Non-cash acquired in-process research and development Contingent Consideration Liabilities expense         1,267 0  
Non-cash gain on long-term investment in preferred stock         0 (3,390)  
Amortization of premium on investments in U.S. Treasury securities, net         19 106  
Changes in operating assets and liabilities:              
Prepaid expenses and other current assets         (4,090) (426)  
Accounts payable         (1,651) (1,761)  
Accrued expenses and other current liabilities         6,775 (3,826)  
Lease liabilities, operating         (1,243) (1,102)  
Lease liabilities, finance         2 (1)  
Net cash used in operating activities         (67,303) (78,482)  
Cash flows from investing activities:              
Proceeds from sales or maturities of investments         85,930 67,200  
Purchases of investments         (31,949) (55,366)  
Purchases of property and equipment         (340) (397)  
Net cash provided by investing activities         53,641 11,437  
Cash flows from financing activities:              
Proceeds from issuance of common stock under the ATM Program, pre-funded warrants and warrants to purchase common stock upon May 2025 Private Placement Offering, gross         39,613 0  
Payments on offering costs incurred by third parties in association with the ATM Program         (1,415) 0  
Proceeds from exercise of common warrants         2,446 0  
Proceeds from exercise of stock options         329 34  
Proceeds from common stock issuances under 2023 ESPP         306 271  
Payments on finance leases (135)   (75)   (398) (364)  
Net cash provided by financing activities         40,881 73,023  
Net change in cash, cash equivalents and restricted cash         27,219 5,978  
Cash, cash equivalents and restricted cash at beginning of period   $ 66,248   $ 38,266 66,248 38,266 $ 38,266
Cash, cash equivalents and restricted cash at end of period 93,467   44,244   93,467 44,244 66,248
Supplemental disclosure of non-cash activities              
Unrealized gain (loss) on investments in U.S. Treasury securities $ (167) $ (330) $ 102 $ 49 (653) 192  
Offering costs reclassified from other current assets to additional paid-in capital         570 0  
Unpaid property and equipment purchases included in accounts payable         481 0  
Amounts reclassified from deposit liabilities to additional paid-in capital upon the vesting of early-exercised stock options previously subject to repurchase         2 33  
May 2025 Private Placement [Member]              
Cash flows from financing activities:              
Proceeds from issuance of common stock under the ATM Program, pre-funded warrants and warrants to purchase common stock upon May 2025 Private Placement Offering, gross         0 79,999  
Payments on offering costs incurred by third parties in association with the ATM Program             $ (6,900)
Payments on third-party commissions and offering costs incurred upon May 2025 Private Placement Offering         $ 0 $ (6,917)